← Patent-cliff monitor Loss of exclusivity October 2033 latest FDA-listed patent expiry
Drug detail Brand name VELTASSA Active ingredient PATIROMER SORBITEX CALCIUM Strength EQ 1GM BASE/PACKET Dosage form POWDER Route ORAL Modality Small molecule FDA approval October 2023 Marketing status RX
Listed patents Patent Expires Type 9925212 October 2033 use U-1766 9492476 October 2033 use U-1766 11123363 October 2033 use U-1766 8337824 May 2030 substance 8147873 June 2028 product 8282913 May 2027 product 8216560 March 2027 use U-1766
Regulatory exclusivity Code Expires NS October 2026
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.